Vbi Vaccines Inc (VBIV) Return on Investment ROI from the first quarter of 2024 to first quarter of 2023 and for the year 2024, average high and low, overall ranking from Mar 31 2024 to Mar 31 2023 - CSIMarket
CSIMarket
 


Vbi Vaccines Inc  (NASDAQ: VBIV)


Vbi Vaccines Inc's ROI from its first quarter of 2024 to the first quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Vbi Vaccines Inc's ROI in the first quarter of 2024?
Vbi Vaccines Inc recorded a cumulative net loss of $-84 million during 12 months ending in the first quarter of 2024, resulting in a negative return on investment (ROI) of -145.86%.

Within the Healthcare sector 833 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2024 quarter, so far to 4610, from total ROI ranking in the fourth quarter of 2023 at 5264.

Definition and Formula of Return on Investment



Return On Investment (Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
Y / Y Investment Change TTM -51.34 % -47.78 % -44.3 % -39.41 % -34.95 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 43 58 70 59 94
Return On Investment (TTM) -145.86 % -133.38 % -136.62 % -118.66 % -101.25 %
VBIV's Overall Ranking # 4610 # 5264 # 4734 # 4804 # 4907
Seq. Investment Change TTM -18.16 % -16.29 % -16 % -15.44 % -12.18 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -84 -94 -115 -119 -120




Return On Investment VBIV's Ranking
Within: No.
Industry # 394
Sector # 834
Overall # 4610

Return On Investment Statistics
High Average Low
30.97 %
-79.29 %
-595.52 %
(Sep 30 2014)   (Sep 30 2015)







Financial Statements
Vbi Vaccines Inc's I. Quarter Investments $ 43 Millions VBIV's Balance sheet
Vbi Vaccines Inc's I. Quarter Income $ -18 Millions Quarterly VBIV's Income Statement
VBIV's Income by Division See VBIV's Income by Division


VBIV Annual Return On Investment (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
Total Investments in Millions 58 113 178 197 108
Y / Y Investment Growth -48.43 % -36.38 % -9.84 % 82.92 % -25.73 %
Net Income in Millions -94 -113 -70 -46 -55
Y / Y Net Income Growth - - - - -
Annual Return On Investment -160.97 % -100.22 % -39.26 % -23.46 % -50.87 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VBIV's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VBIV's Competitors
Subscribers only: Roi for Vbi Vaccines Inc's Suppliers
Subscribers only: Return On Investment for VBIV's Customers

Other Ratios
VBIV's Roa VBIV's Inventory Turnover Ratio VBIV's Growth Rates VBIV's Dividend Statistics
VBIV's Profitability Ratios VBIV's Asset Turnover Ratio VBIV's Dividend Growth
VBIV's Roe VBIV's Valuation Ratios VBIV's Financial Strength Ratios VBIV's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2024, within Healthcare Sector ROI


Date modified: 2026-09-26T07:31:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.